CureVac announces dosing of first participant in Phase 2 study of influenza

MLA

“CureVac Announces Dosing of First Participant in Phase 2 Study of Influenza.” The Fly, May 2024. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.795527053&authtype=sso&custid=ns315887.

APA

CureVac announces dosing of first participant in Phase 2 study of influenza. (2024, May 28). The Fly.

Chicago

The Fly. 2024. “CureVac Announces Dosing of First Participant in Phase 2 Study of Influenza,” May 28. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.795527053&authtype=sso&custid=ns315887.